Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Amorphous form of an AKT inhibiting pyrimidinyl-cyclopentane compound, compositions and methods thereof

Amorphous form of an AKT inhibiting pyrimidinyl-cyclopentane compound, compositions and methods thereof

US Patent 9290458 · Granted Mar 22, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical compositions comprising AKT protein kinase inhibitors2025
Polymorphs and solid forms of (S)-2-2((2-((S)-4-(difluoromethyl)-2-oxooxazolidin2025
Polymorphs and solid forms of (S)-2-2((2-((S)-4-(difluoromethyl)-2-oxooxazolidin2025
Compounds and compositions for the inhibition of NAMPT2025
Synthesis of quinazoline compounds2024
Process for synthesis of quinazoline compounds2024
Synthesis of a bis-mesylate salt of 4-amino-N-(1-((3-chloro-2-fluorophenyl)amino2024
Pharmaceutical compositions comprising Akt protein kinase inhibitors2024
Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3- yl)a2023
Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3- yl)a2023
Process for making arylomycin ring analogs2023
Process for preparing BTK inhibitors2023